• Mashup Score: 0

    WASHINGTON — Adults with central sleep apnea on adaptive servo-ventilation for 12 months had improved disease-specific quality of life, according to an abstract presented at the American Thoracic Society International Conference.“Improvement of disease-specific quality of life is one major component of the indication for the therapy of adaptive servo-ventilation,” Michael Arzt,

    Tweet Tweets with this article
    • “The main message is that disease-specific quality of life and the leading symptom, daytime #sleepiness, statistically and clinically significantly improves,” Michael Arzt, MD, at University Hospital Regensburg, told Healio at #ATS2023. https://t.co/nwQMtSPoWa

  • Mashup Score: 0

    Dr. Joey Fredrick joins us to discuss the association between sluggish cognitive tempo, circadian preference, sleep, & daytime sleepiness.

    Tweet Tweets with this article
    • In this podcast, @joey_fredrick provides us with an insight into what sluggish cognitive tempo is, before turning to his co-authored @theJCPP paper on sluggish cognitive tempo in relation to adolescent #sleep, daytime #sleepiness, & #circadian preference. https://t.co/ewKHFkQkNf https://t.co/6v5f2Atbyt

  • Mashup Score: 0

    Study participants recorded what they were doing every thirty minutes, estimated their level of sleepiness every three hours, and filled out a sleep diary every morning for three weeks.

    Tweet Tweets with this article
    • “Our study opens the door to new research on how factors such as daylight, coffee, sleep treatments, and other factors that reduce #sleepiness can help us live more social lives.” https://t.co/Mg2egAO7UN https://t.co/sFn2Oc94tg

  • Mashup Score: 1

    Treatment with pitolisant, as compared with placebo, reduced excessive daytime sleepiness and improved several other outcomes among patients with obstructive sleep apnea who refuse CPAP, according to a study published in the American Journal of Respiratory and Critical Care. Specifically, from baseline to 12 weeks, the Epworth Sleepiness Scale (ESS) score decreased by 6.3 points among patients

    Tweet Tweets with this article
    • Treatment with pitolisant, as compared with placebo, reduced excessive daytime #sleepiness and improved several other outcomes among patients with #sleepapnea who refuse #CPAP, according to a study published in @ATSBlueEditor https://t.co/6MqvqxNt93